<p>Integrative gene expression profiling reveals that dysregulated triple microRNAs confer paclitaxel resistance in non-small cell lung cancer via co-targeting MAPT</p>

Yuanming Cai(Xinjiang Medical University), Shuiliang Wang(Xiamen University)
Cancer Management and Research
August 1, 2019
10.2147/cmar.s215427
Cited by 18

Related Papers

Therapeutic targeting of erbB3 with MM-121/SAR256212 enhances antitumor activity of paclitaxel against erbB2-overexpressing breast cancer
|Breast Cancer Research|2013|56
Valproic acid exhibits anti-tumor activity selectively against EGFR/ErbB2/ErbB3-coexpressing pancreatic cancer via induction of ErbB family members-targeting microRNAs
|Journal of Experimental & Clinical Cancer Research|2019|40
MicroRNA-mediated epigenetic targeting of Survivin significantly enhances the antitumor activity of paclitaxel against non-small cell lung cancer
|Oncotarget|2016|27